RxDoctor Payments Data

Michael Levin

Internal Medicine · Baltimore, MDNPI 1902906753

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $10,674 of the $14,214 with a category attached, or 75.1%. Gilead accounts for 91.3% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $11,911 and has fallen 99.0% since, to $125 in 2023. Among internal medicine clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,214in general payments, 2019–2025

Across 112 payments — averaging $126.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$13K
  • Viiv Healthcare Company$261
  • Merck$160
  • Amgen$154
  • Dova Pharmaceuticals$120
  • Janssen Products, LP$101
  • plus $438 from 15 others

What the payments were for

  • Speaking & faculty fees$10,67475%
  • Travel & lodging$1,42410%
  • Food & beverage$2,11615%

General payments by program year

19
20
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,214 in reported general payments places this provider in the 95th percentile of 2,979 internal medicine providers in Maryland.

See all internal medicine providers in Maryland →

Other internal medicine in Baltimore

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →